Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.06 and traded as high as $2.06. Pulmatrix shares last traded at $2.00, with a volume of 3,923 shares trading hands.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on shares of Pulmatrix in a report on Friday. They set a “hold” rating for the company.
View Our Latest Stock Analysis on PULM
Pulmatrix Stock Down 2.4 %
Pulmatrix (NASDAQ:PULM – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.87) earnings per share (EPS) for the quarter. Pulmatrix had a negative return on equity of 46.86% and a negative net margin of 95.18%. The business had revenue of $1.55 million during the quarter.
Pulmatrix Company Profile
Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Further Reading
- Five stocks we like better than Pulmatrix
- There Are Different Types of Stock To Invest In
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Short Selling: How to Short a Stock
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Insider Trades May Not Tell You What You Think
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.